Artesunate + Amodiaquine is a fixed-dose combination antimalarial medication used for the treatment of uncomplicated Plasmodium falciparum malaria. Artesunate, a fast-acting artemisinin derivative, rapidly reduces the parasite load, while Amodiaquine, a longer-acting partner drug, eliminates remaining parasites and helps prevent recurrence. This combination is recommended in many malaria-endemic regions due to its high efficacy, good tolerability, and role in combating drug resistance.